CareMax, Inc. - Class A Common Stock (CMAX)
0.4215
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 2nd, 7:29 PM EDT

Via Benzinga · November 25, 2024

Via Benzinga · November 25, 2024

Via Benzinga · November 25, 2024

Via Benzinga · November 25, 2024

Via Benzinga · November 18, 2024

Via Benzinga · November 18, 2024

CareMax Inc. announces asset sales under a Chapter 11 plan, backed by lenders, and secures $30.5 million in financing. Key details on management services divestment.
Via Benzinga · November 18, 2024

Via Benzinga · November 18, 2024

Via Benzinga · October 30, 2024

Via Benzinga · October 18, 2024

Via Benzinga · September 2, 2024

It's time to dive into the biggest pre-market stock movers for Monday morning with all of the latest news affecting shares today!
Via InvestorPlace · August 12, 2024

Via Benzinga · August 12, 2024

CMAX stock results show that CareMax missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 9, 2024

Pre-market stock movers are a hot topic that traders are going to want to know about and we have all of the latest news on Tuesday morning!
Via InvestorPlace · July 23, 2024

Via Benzinga · July 23, 2024

Via Benzinga · July 26, 2024

Shares of CareMax, Inc. (NASDAQ: CMAX) are trading significantly higher on Monday. Here's what you need to know.
Via Benzinga · July 22, 2024

Via Benzinga · July 23, 2024

Via Benzinga · July 22, 2024

CMAX stock results show that CareMax missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 9, 2024

Via Benzinga · April 24, 2024

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.
Via Benzinga · April 15, 2024